National Guideline Clearinghouse | Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome.

full-text ►

National Guideline Clearinghouse | Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome. London (UK): National Institute for Health and Care Excellence (NICE); 2015 Mar. 43 p. (Technology appraisal guidance; no. 335).

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.